A Study to Evaluate the Safety and Pharmacokinetics of Ataluren in Participants From ≥6 Months to < 2 Years of Age With Nonsense Mutation Duchenne Muscular Dystrophy (nmDMD)

Condition:   Duchenne Muscular Dystrophy Intervention:   Drug: Ataluren Sponsor:   PTC Therapeutics Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials